Monopar Therapeutics Inc. buy blaugold
Start price
30.05.23
/
50%
€0.98
Target price
30.05.24
-
Performance (%)
-11.28%
End price
11.06.23
€0.87
Summary
This prediction ended on 11.06.23 with a price of €0.87. The price of Monopar Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.28%. blaugold has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Monopar Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % | 51,69 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % | 67,99 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % | 57,11 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % | 58,87 % |
According to blaugold what are the pros and cons of Monopar Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by blaugold for this prediction
In the thread Monopar Therapeutics Inc. diskutieren
Buy Monopar Therapeutics Inc.